Zocor
Zocor® (Simvastatin) Tablets
DESCRIPTION Zocor
Uses Zocor
ZOCOR is a prescription tablet and isn’t right for everyone, including women
who are nursing or pregnant or who may become pregnant, and anyone with liver
problems. Unexplained muscle pain or weakness could be a sign of a rare
but serious side effect and should be reported to your doctor right away.
ZOCOR may interact with other medicines or certain foods, increasing your
risk of getting this serious side effect. So tell your doctor about any
other medications you are taking.
ZOCOR is a prescription drug that is indicated as an addition to diet for many
patients with high cholesterol when diet and exercise are inadequate. For patients
with coronary heart disease (CHD) and high cholesterol, ZOCOR is indicated as
an addition to diet to reduce the risk of death by reducing coronary death; to
reduce the risk of heart attack; to reduce the risk for undergoing cardiac
procedures (coronary artery bypass grafting and percutaneous transluminal
coronary angioplasty); and to reduce the risk of stroke or transient ischemic
attack (TIA).
Drug monograph "Zocor"
When Zocor should not be used
Some people should not take ZOCOR. Discuss this with your doctor.
ZOCOR should not be used by patients who are allergic to any of its ingredients.
In addition to the active ingredient simvastatin, each tablet contains the following
inactive ingredients: cellulose, lactose, magnesium stearate, iron oxides, talc,
titanium dioxide, and starch. Butylated hydroxyanisole is added as a preservative.
Patients with liver problems Zocor:
ZOCOR should not be used by patients with active liver disease or repeated blood
test results indicating possible liver problems. (See WARNINGS.)
Women who are or may become pregnant Zocor:
Pregnant women should not take ZOCOR because it may harm the fetus. Women of
childbearing age should not take ZOCOR unless it is highly unlikely that they
will become pregnant. If a woman does become pregnant while on ZOCOR, she should
stop taking the drug and talk to her doctor at once.
Women who are breast-feeding should not take ZOCOR.
Patients who are also taking the prescription drug Posicor
(mibefradil) should not take ZOCOR.
Warnings Zocor
Liver: About 1% of patients who took ZOCOR in clinical trials developed
elevated levels of some liver enzymes. Patients who had these increases usually
had no symptoms. Elevated liver enzymes usually returned to normal levels when
therapy with ZOCOR was stopped.
In the ZOCOR Survival Study, the number of patients with more than
one liver enzyme level elevation to greater than 3 times the normal upper
limit was no different between the ZOCOR and placebo groups. Only 8 patients
on ZOCOR and 5 on placebo discontinued therapy due to elevated liver enzyme
levels. Patients were started on 20 mg of ZOCOR, and one third had their dose
raised to 40 mg.
Your doctor should perform routine blood tests to check these enzymes before
you start treatment with ZOCOR and periodically thereafter
(for example, semiannually) for your first year of treatment or until one year
after your last elevation in dose. If your enzyme levels increase, your doctor
should order more frequent tests. If your liver enzyme levels remain unusually
high, your doctor should discontinue your medication.
Tell your doctor about any liver disease you may have had in the past and
about how much alcohol you consume. ZOCOR should be used with caution in patients
who consume large amounts of alcohol.
Muscle: Tell your doctor right away if you experience any muscle pain,
tenderness, or weakness at any time during treatment with ZOCOR, particularly
if you have a fever or if you are generally not feeling well, so your doctor
can decide if ZOCOR should be stopped. Some patients may have muscle pain or
weakness while taking ZOCOR. Rarely, this can include muscle breakdown resulting
in kidney damage. The risk of muscle breakdown is greater in patients taking
certain other drugs along with ZOCOR, such as the lipid-lowering drug Lopid
(gemfibrozil), a fibrate; lipid-lowering doses of nicotinic acid (niacin);
the antibiotics erythromycin and clarithromycin; nefazodone; antifungal drugs
that are azole derivatives, such as itraconazole and ketoconazole; the calcium
channel blocker Posicor; or drugs that suppress the immune system (called
immunosuppressive drugs, such as Sandimmune [cyclosporine]). Therapy with
ZOCOR should be temporarily interrupted if you are going to take an azole
derivative antifungal medication, such as itraconazole. Patients using ZOCOR
along with any of these other drugs should be carefully monitored by their
physician. The risk of muscle breakdown is greater in patients with kidney
problems or diabetes.
If you have conditions that can increase your risk of muscle breakdown,
which in turn can cause kidney damage, your doctor should temporarily
withhold or stop ZOCOR. Such conditions include severe infection, low blood
pressure, major surgery, trauma, severe metabolic, endocrine and electrolyte
disorders, and uncontrolled seizures. Also, since there are no known adverse
consequences of briefly stopping therapy with ZOCOR, treatment should be
stopped a few days before elective major surgery. Discuss this with your
doctor, who can explain these conditions to you.
Because there are risks in combining therapy with ZOCOR with lipid-lowering
doses of nicotinic acid (niacin) or with drugs that suppress the immune
system, your doctor should carefully weigh the potential benefits and
risks. He or she should also carefully monitor patients for any muscle pain,
tenderness, or weakness, particularly during the initial months
of therapy and if the dose of either drug is increased. Your doctor may
also monitor the level of certain muscle enzymes in your body, but there
is no assurance that such monitoring will prevent the occurrence of severe
muscle disease.
Precautions "Zocor"
Before starting treatment with ZOCOR, try to lower your cholesterol by
other methods such as diet, exercise, and weight loss. Ask your doctor
about how best to do this. Any other medical problems that can cause high
cholesterol should also be treated.
ZOCOR is less effective in patients with the rare disorder known as
homozygous familial hypercholesterolemia.
Drug Interactions Zocor:
Because of possible serious drug interactions, it is important to tell your
doctor what other drugs you are taking, including those obtained without a
prescription.
ZOCOR can interact with Posicor, Lopid, niacin, erythromycin, clarithromycin,
nefazodone, certain antifungal drugs, and drugs that suppress the immune
system (called immunosuppressive drugs, such as Sandimmune).
(See WARNINGS, Muscle.)
Some patients taking lipid-lowering agents similar to ZOCOR and coumarin
anticoagulants (a type of blood thinner) have experienced bleeding
and/or increased blood clotting time. Patients taking these medicines
should have their blood tested before starting therapy with ZOCOR and
should continue to be monitored.
Endocrine (Hormone) Function Zocor:
ZOCOR and other drugs in this class may affect the production of certain hormones.
Caution should be exercised if a drug used to lower cholesterol levels is
administered to patients also receiving other drugs (e.g., ketoconazole,
spironolactone, cimetidine) that may decrease the levels or activity
of hormones. If you are taking any such drugs, tell your doctor.
Central Nervous System Toxicity; Cancer, Mutations, Impairment of Fertility Zocor:
Like most prescription drugs, ZOCOR was required to be tested on animals before
it was marketed for human use. Often these tests were designed to achieve higher
drug concentrations than humans achieve at recommended dosing. In some tests,
the animals had damage to the nerves in the central nervous system. In
studies of mice with high doses of ZOCOR, the likelihood of certain types of
cancerous tumors increased. No evidence of mutations of or damage to genetic
material has been seen. In one study with ZOCOR, there was decreased fertility
in male rats.
Pregnancy Zocor:
Pregnant women should not take ZOCOR because it may harm the fetus.
Safety in pregnancy has not been established. In studies with lipid-lowering
agents similar to ZOCOR, there have been rare reports of birth defects of
the skeleton and digestive system. Therefore, women of childbearing age should
not take ZOCOR unless it is highly unlikely they will become pregnant. If
a woman does become pregnant while taking ZOCOR, she should stop taking the
drug and talk to her doctor at once. The active ingredient of ZOCOR did not
cause birth defects in rats at 6 times the human dose or in rabbits at 4 times
the human dose.
Nursing Mothers Zocor:
Drugs taken by nursing mothers may be present in their breast milk.
Because of the potential for serious adverse reactions in nursing infants,
a woman taking ZOCOR should not breast-feed. (See WHEN ZOCOR SHOULD NOT BE USED.)
Pediatric Use Zocor:
ZOCOR is not recommended for children or patients under 20 years of age.
Side effects "Zocor"
Most patients tolerate treatment with ZOCOR well; however, like all prescription
drugs, ZOCOR can cause side effects, and some of them can be serious. Side effects
that do occur are usually mild and short-lived. Only your doctor can weigh the
risks versus the benefits of any prescription drug. In clinical studies with ZOCOR,
less than 1.5% of patients dropped out of the studies because of side effects.
In a large, long-term study, patients taking ZOCOR experienced similar side
effects to those patients taking placebo (sugar pills). Some of the side effects
that have been reported with ZOCOR or related drugs are listed below. This list
is not complete. Be sure to ask your doctor about side effects before taking ZOCOR
and to discuss any side effects that occur.
Digestive System Zocor:
Constipation, diarrhea, upset stomach, gas, heartburn, stomach pain/cramps, anorexia,
loss of appetite, nausea, inflammation of the pancreas, hepatitis, jaundice, fatty
changes in the liver, and, rarely, severe liver damage and failure, cirrhosis,
and liver cancer.
Muscle, Skeletal Zocor:
Muscle cramps, aches, pain, and weakness; joint pain; muscle breakdown.
Nervous System Zocor:
Dizziness, headache, insomnia, tingling, memory loss, damage to nerves causing
weakness and/or loss of sensation and/or abnormal sensations, anxiety, depression,
tremor, loss of balance, psychic disturbances.
Skin Zocor:
Rash, itching, hair loss, dryness, nodules, discoloration.
Eye/Senses Zocor:
Blurred vision, altered taste sensation, progression of cataracts, eye muscle weakness.
Hypersensitivity (Allergic) Reactions Zocor:
On rare occasions, a wide variety of symptoms have been reported to occur either
alone or together in groups (referred to as a syndrome) that appeared to be based
on allergic-type reactions, which may rarely be fatal. These have included one or
more of the following: a severe generalized reaction that may include shortness of
breath, wheezing, digestive symptoms, and low blood pressure and even shock; an
allergic reaction with swelling of the face, lips, tongue and/or throat with
difficulty swallowing or breathing; symptoms mimicking lupus (a disorder in which
a person's immune system may attack parts of his or her own body); severe muscle
and blood vessel inflammation; bruises; various disorders of blood cells (that could
result in anemia, infection, or blood clotting problems) or abnormal blood tests;
inflamed or painful joints; hives; fatigue and weakness; sensitivity to sunlight;
fever, chills; flushing; difficulty breathing; and severe skin disorders that vary
from rash to a serious burn-like shedding of skin all over the body, including mucous
membranes such as the lining of the mouth.
Other Zocor:
Loss of sexual desire, breast enlargement, impotence.
Laboratory Tests Zocor:
Liver function test abnormalities including elevated alkaline phosphatase and
bilirubin; thyroid function abnormalities.
NOTE Zocor:
This summary provides important information about ZOCOR. If you would like
more information, ask your doctor or pharmacist to let you read the professional
labeling and then discuss it with them.
|